Skip to content
← Back to this collection

PUBLICATIONS · 29733771

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Oct 20
First author
Lewin J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Oct 20;36(30):3040-3042. doi: 10.1200/JCO.2018.78.8695.
    note
    Source null
    related pmid
    29847297
    relationship
    Comment in

Authors and identifiers

  1. name
    Lewin J
    type
    Author
  2. name
    Soria JC
    type
    Author
  3. name
    Stathis A
    type
    Author
  4. name
    Delord JP
    type
    Author
  5. name
    Peters S
    type
    Author
  6. name
    Awada A
    type
    Author
  7. name
    Aftimos PG
    type
    Author
  8. name
    Bekradda M
    type
    Author
  9. name
    Rezai K
    type
    Author
  10. name
    Zeng Z
    type
    Author
  11. name
    Hussain A
    type
    Author
  12. name
    Perez S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lewin J
    type
    Author
  2. name
    Soria JC
    type
    Author
  3. name
    Stathis A
    type
    Author
  4. name
    Delord JP
    type
    Author
  5. name
    Peters S
    type
    Author
  6. name
    Awada A
    type
    Author
  7. name
    Aftimos PG
    type
    Author
  8. name
    Bekradda M
    type
    Author
  9. name
    Rezai K
    type
    Author
  10. name
    Zeng Z
    type
    Author
  11. name
    Hussain A
    type
    Author
  12. name
    Perez S
    type
    Author
bibliography ids
  1. nci-bib-ee16acbf777c0fa159a82b71
book metadata
content sha256
d25b7c50b152a0ec1d2c7b8fde97fe1fff740fa556628442f4e1f9f2f336a46d
document type
citation
dois
  1. 10.1200/JCO.2018.78.2292
electronic publication date
display
2018 May 7
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29733771
immutable id
pubmed:29733771@d25b7c50b152a0ec1d2c7b8fde97fe1fff740fa556628442f4e1f9f2f336a46d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
30
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3007-3014
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Oct 20;36(30):3040-3042. doi: 10.1200/JCO.2018.78.8695.
    note
    Source null
    related pmid
    29847297
    relationship
    Comment in
outcomes validated
false
pmid
29733771
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
d01dd3c5037341a5f7314a8d8e7210aedf6a36243eca76e5272a5178122f7f05
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Oct 20
precision
day
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29733771/
title
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors.

Preserved source evidence · Not medical advice